SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
RFK Jr. and the Food and Drug Administration unexpectedly snubbed an annual meeting on the flu vaccine, potentially devastating its roll-out in 2025-2026.
Inside a single-story brick building in Sorrento Mesa is a small lab sprinkled with beakers, test tubes and incubators that ...
8d
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Most flu infections this season are from a new variant not covered by the flu shot, but doctors say the vaccine will still ...
Moderna CEO Stéphane Bancel positions 2026 as a catalyst-rich year driven by new vaccine launches, late-stage oncology data, ...
The FDA plans to tighten vaccine approval standards, requiring more evidence of safety and efficacy. Georgia doctors warn the move could discourage vaccination and reduce vaccine development. The ...
WASHINGTON (AP) — Flu is rising rapidly across the U.S., driven by a new variant of the virus — and cases are expected to ...
In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback